Furthermore, the chemo-tolerant subpopulation in both basal-like and luminal breast cancer cell lines co-express both an epithelial marker CD24 and a mesenchymal marker CD44 [85], indicating its hybrid E/M status [11]. The gene discussed is CD44; the disease is breast cancer.